S

Shree Ganesh Remedies Limited

SGRL
Market snapshot · 2026-08-11 09:46 UTC

622.00

+₹15.55 (+2.56%)

MARKET CAP

₹798.50 Cr

STOCK P/E

45.0x

52W HIGH

₹759.00

52W LOW

₹381.10

BOOK VALUE

₹126.95

EPS

₹13.81

ROE

11.53%

SECTOR

Health Care

DEBT/EQUITY

18.91

VOLUME

20,048

P/B RATIO

4.90x

PEG RATIO

Sector

Health Care

Themes

Pharmaceuticals
₹709.55₹637.93₹566.30₹494.68₹423.05VolumeAug '25Sep '25Nov '25Jan '26Mar '26Apr '26Jun '26Aug '26

AI Summary

✦ Clartha

Valuation Metrics

Trading 1.7% below historical median. Valuation is declining — currently in the undervalued zone (z-score: -0.09). Confidence: 81%.

Forward Valuation Outlook

Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.

P/E
Undervalued

5Y Average

35.95

Current

44.67

Overvalued

51.39

Undervalued

37.14

EV/EBITDA
Overvalued

5Y Average

18.00

Current

22.37

Overvalued

23.16

Undervalued

11.27

P/S
Overvalued

5Y Average

5.83

Current

7.25

Overvalued

7.50

Undervalued

3.65

Peers & Comparison

No peer data available for this company.
WHY THESE PEERS

No sector data available for this company.

Financials

Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.

Latest revenue

₹33 CrMar 2026

Latest net profit

₹6.00 CrMar 2026

Latest EPS

₹4.88Mar 2026

Net margin

25.8%Mar 2026

Performance

Bars show revenue and net profit. The line shows net margin.

Rs crore + margin %
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '260.0%8.0%16.0%24.0%32.0%0.00 Cr9.00 Cr18 Cr27 Cr36 Cr
  • Revenue
  • Net income
  • Net margin %

Earnings

Revenue is shown in crores. EPS is rupees per share.

Rs crore + Rs/share
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '260.00 Cr9.00 Cr18 Cr27 Cr36 Cr₹0₹2₹4₹6₹8
  • Revenue
  • EPS

Revenue to profit conversion

Bridge from operating numbers to profit for the latest reported period.

Rs crore
RevenueExpensesDepreciationOtheradjustmentsOperatingprofitOther incomeInterestProfitbefore taxTax & otherNet Profit0.00 Cr9.00 Cr18 Cr27 Cr36 Cr

Latest reported period: Mar 2026

Debt level and coverage

Debt, cash and free cash flow compared on the same crore scale.

Rs crore
Annual view
Mar 2025Sep 2025Mar 20260.00 Cr55 Cr110 Cr165 Cr220 Cr
  • Debt
  • Free cash flow
  • Cash & equivalents

Results

Sales

₹33 Cr

+35.9%

Net Profit

₹6 Cr

-4.9%

EBITDA

₹12 Cr

+1.9%

EPS

₹4.88

-4.9%
MetricMar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales2425302133
Expenses1720231725
Operating Profit75749
OPM %30.51%19.77%23.19%19.25%25.83%
Other Income21111
Interest11111
Depreciation22333
Profit before tax95749
Tax %24.87%25.07%26.16%22.39%28.1%
Net Profit73536
EPS in Rs5.132.683.862.414.88

All values in ₹ Crores unless otherwise stated. Source: Company filings.

Loading shareholding pattern...